Atlas Trials

Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer

Clinical trial NCT02152137 · COMPLETED

Trial details

NCT number
NCT02152137
Sponsor
Alliance for Clinical Trials in Oncology
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Anaplastic Thyroid CancerRecurrent Thyroid Cancer
Start date
2014-12-30
Primary completion
2019-02-27
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.